In AD brains, EAAT1 and EAAT2 expression is significantly decreased (Jacob et al., 2007), possibly contributing to an increase in glutamate levels at both the synaptic cleft and perisynaptic area to trigger excessive activation of extrasynaptic NMDA receptors. This evidence concerns the gene SLC1A2 and Alzheimer disease.